Literature DB >> 19614609

Induced sputum: a window to lung pathology.

Ben Nicholas1, Ratko Djukanović.   

Abstract

Sputum is recognized as a sampling method for the monitoring and assessment of chronic lung diseases such as asthma, COPD (chronic obstructive pulmonary disease) and cystic fibrosis. Sputum samples the central airways and its protein components (e.g. mucins and cytokines), cellular components (e.g. eosinophils and neutrophils) and microbiological components (e.g. viruses and bacteria) can be used as markers of disease severity, exacerbation, susceptibility or progression. This paper describes the basic constituents of induced sputum and how these influence the quantification and identification of novel biomarkers of chronic lung diseases using techniques such as proteomics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19614609     DOI: 10.1042/BST0370868

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

1.  Lab-on-a-Film disposable for genotyping multidrug-resistant Mycobacterium tuberculosis from sputum extracts.

Authors:  Alexander C Kukhtin; Thomas Sebastian; Julia Golova; Alex Perov; Christopher Knickerbocker; Yvonne Linger; Arial Bueno; Peter Qu; Michael Villanueva; Rebecca C Holmberg; Darrell P Chandler; Christopher G Cooney
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

2.  Chemokine expression by small sputum macrophages in COPD.

Authors:  Marion Frankenberger; Christiane Eder; Thomas P J Hofer; Irene Heimbeck; Kerstin Skokann; Gudrun Kassner; Norbert Weber; Winfried Möller; Loems Ziegler-Heitbrock
Journal:  Mol Med       Date:  2011-02-09       Impact factor: 6.354

Review 3.  A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.

Authors:  Kedir N Turi; Lindsey Romick-Rosendale; Kelli K Ryckman; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

4.  Induced sputum proteome in healthy subjects and asthmatic patients.

Authors:  Sina A Gharib; Elizabeth V Nguyen; Ying Lai; Jessica D Plampin; David R Goodlett; Teal S Hallstrand
Journal:  J Allergy Clin Immunol       Date:  2011-09-08       Impact factor: 10.793

5.  Isolation and characterization of microparticles in sputum from cystic fibrosis patients.

Authors:  Chiara Porro; Silvia Lepore; Teresa Trotta; Stefano Castellani; Luigi Ratclif; Anna Battaglino; Sante Di Gioia; Maria C Martínez; Massimo Conese; Angela B Maffione
Journal:  Respir Res       Date:  2010-07-09

6.  Protein networks in induced sputum from smokers and COPD patients.

Authors:  James N Baraniuk; Begona Casado; Lewis K Pannell; Peter B McGarvey; Piera Boschetto; Maurizio Luisetti; Paolo Iadarola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-15

7.  Differences in airway inflammation according to atopic status in patients with chronic rhinitis.

Authors:  Jae-Woo Kwon; Tae-Wan Kim; Kyung-Mook Kim; Jae-Woo Jung; Sang-Heon Cho; Kyung-Up Min; You-Young Kim; Heung-Woo Park
Journal:  Asia Pac Allergy       Date:  2012-10-31

8.  Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.

Authors:  David Collie; Laura Glendinning; John Govan; Steven Wright; Elisabeth Thornton; Peter Tennant; Catherine Doherty; Gerry McLachlan
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

Review 9.  Application of proteomics and peptidomics to COPD.

Authors:  Girolamo Pelaia; Rosa Terracciano; Alessandro Vatrella; Luca Gallelli; Maria Teresa Busceti; Cecilia Calabrese; Cristiana Stellato; Rocco Savino; Rosario Maselli
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

10.  Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.

Authors:  Julia Hentschel; Manuela Jäger; Natalie Beiersdorf; Nele Fischer; Franziska Doht; Ruth K Michl; Thomas Lehmann; Udo R Markert; Klas Böer; Peter M Keller; Mathias W Pletz; Jochen G Mainz
Journal:  BMC Pulm Med       Date:  2014-05-13       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.